ID   FHS024i-sh16126E
AC   CVCL_YY55
SY   iPSC - 16126E
DR   BioSample; SAMN06093732
DR   GEO; GSM2411814
DR   WiCell; fhs024i-sh16126e
DR   Wikidata; Q98126085
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 3231; CELSR2; Simple; c.*919G>T; dbSNP=rs12740374; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY54 ! FHS023i-sh16126C
SX   Male
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 7
//
RX   PubMed=28388431; DOI=10.1016/j.stem.2017.01.010;
RA   Warren C.R., O'Sullivan J.F., Friesen M., Becker C.E., Zhang X.-L.,
RA   Liu P.-C., Wakabayashi Y., Morningstar J.E., Shi X., Choi J., Xia F.,
RA   Peters D.T., Florido M.H.C., Tsankov A.M., Duberow E.A., Comisar L.,
RA   Shay J., Jiang X., Meissner A., Musunuru K., Kathiresan S.,
RA   Daheron L., Zhu J., Gerszten R.E., Deo R.C., Vasan R.S.,
RA   O'Donnell C.J., Cowan C.A.;
RT   "Induced pluripotent stem cell differentiation enables functional
RT   validation of GWAS variants in metabolic disease.";
RL   Cell Stem Cell 20:547-557.e7(2017).
//